Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Dr. Christopher U. Meduri

Interventional Cardiology | Emergency Medicine
Stern Cardiovascular Foundation, Inc
8060 Wolf River Blvd, 
Germantown, TN 
Clinical Trials:Currently Recruiting for 3 Trials
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Stern Cardiovascular Foundation, Inc
8060 Wolf River Blvd, 
Germantown, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christopher Meduri is an Interventional Cardiologist and an Emergency Medicine provider in Germantown, Tennessee. Dr. Meduri is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Supravalvular Aortic Stenosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 46 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Specialties
Interventional Cardiology
Emergency Medicine
Licenses
Internal Medicine in NC
Hospital Affiliations
Baptist Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

STERN CARDIOVASCULAR FOUNDATION, INC
8060 Wolf River Blvd, Germantown, TN 38138

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Enrollment Status: Recruiting
Publish Date: October 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)
Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)
Enrollment Status: Recruiting
Publish Date: May 01, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Enrollment Status: Terminated
Publish Date: August 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Device
Study Phase: Not Applicable
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: November 18, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: September 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

46 Total Publications

DurAVR - a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI.
DurAVR - a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: September 17, 2025
Similar Doctors
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. David H. Kraus
Interventional Cardiology | Advanced Heart Failure and Transplant Cardiology | Cardiology
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. David H. Kraus
Interventional Cardiology | Advanced Heart Failure and Transplant Cardiology | Cardiology

Stern Cardiovascular Foundation, Inc

8060 Wolf River Blvd, 
Germantown, TN 
 (0.1 miles away)
901-271-1000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

David Kraus is an Interventional Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Germantown, Tennessee. Dr. Kraus is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Cardiomyopathy, Coronary Heart Disease, Atherosclerosis, and Angina. Dr. Kraus is currently accepting new patients.

Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Arsalan T. Shirwany
Interventional Cardiology | Interventional Radiology | Cardiology
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Arsalan T. Shirwany
Interventional Cardiology | Interventional Radiology | Cardiology

Stern Cardiovascular Foundation, Inc

6027 Walnut Grove Rd, Suite 112, 
Memphis, TN 
 (4.0 miles away)
901-271-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arsalan Shirwany is an Interventional Cardiologist and an Interventional Radiologist in Memphis, Tennessee. Dr. Shirwany is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, Endoscopy, and Heart Bypass Surgery. Dr. Shirwany is currently accepting new patients.

Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Ray M. Allen
Interventional Cardiology | Cardiology
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Ray M. Allen
Interventional Cardiology | Cardiology

Stern Cardiovascular Foundation, Inc

6027 Walnut Grove Rd, Suite 112, 
Memphis, TN 
 (4.0 miles away)
901-271-1000
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ray Allen is an Interventional Cardiologist and a Cardiologist in Memphis, Tennessee. Dr. Allen has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, Heart Bypass Surgery, and Pacemaker Implantation. Dr. Allen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Meduri's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile